Terrance P. Coyne sold $646K of RPRX stock

Terrance P. Coyne, EVP & CFO of Royalty Pharma plc (RPRX), sold 11,002 shares of RPRX stock worth $646K, per an SEC Form 4 filed Aug 17, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Aug 13, 2026, 4 days before it was made public.

RPRX has moved +17.8% since the trade date, from $58.56 to $68.97 (Nov 12, 2026 close).